ProfileGDS4459 / ENSG00000063515
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 77% 77% 61% 74% 62% 69% 61% 55% 58% 59% 70% 56% 61% 65% 56% 68% 80% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.7477
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.6577
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.8961
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.4574
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.8962
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.2169
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.961
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.5555
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.7158
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.8259
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.2370
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.6156
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.961
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9665
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.6256
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.168
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.9280